A comparison of the DGGE profiles generated from the cecal microbiota of rats showed that the HV-containing diet produced a large, highly consistent difference in microbiota composition relative to the other diets. Therefore, we investigated the composition of the microbiota of HV-fed and cellulose-fed animals in more detail. The DGGE profiles generated from the cecal microbiota of HV-fed rats contained a 16S rRNA fragment that was more intensely stained than in corresponding profiles of cellulose-fed rats. This rRNA gene sequence originated from bacteria with identity to
L. acidophilus. The abundance of rRNAs derived from
L. acidophilus in cecal contents from HV-fed rats was greater than that in cecal contents from cellulose-fed animals. Bacterial rRNA can be used as an indicator of metabolic activity because the ribosome-to-cell ratio is roughly proportional to the growth rate of the bacteria (
15). The proportion of
Lactobacillus 16S rRNA sequences randomly cloned from cDNAs from the cecal microbiota of HV-fed rats was greater than that in the case of cellulose-fed rats. This supported the outcome of the DNA-RNA hybridization experiment: copies of the 16S rRNA genes of lactobacilli were more prevalent in HV-fed rats. FISH/flow cytometry analysis of the microbiota showed that the increased abundance of
Lactobacillus rRNAs was in fact due to the presence of large populations of
L. acidophilus in the ceca of HV-fed rats relative to those of cellulose-fed animals. Therefore, consumption of the HV diet did not just increase bacterial metabolic activity, which is sometimes the only outcome of prebiotic administration (
37), but resulted in increased numbers of
Lactobacillus cells.
Lactobacillus strains belonging to the
L. acidophilus group (
L. crispatus,
L. gasseri, amd
L. johnsonii) as well as
L. hamsteri, cultured in medium containing β-glucan hydrolysates, utilized oligosaccharides of short chain length (DP3). The type culture strain of
L. acidophilus that we tested did not utilize oligosaccharides in the hydrolysates. There may be strain-to-strain variation in this species with regard to the ability to utilize oligosaccharides, but we did not test this possibility. We presume that DP3 oligosaccharides were the substrates that produced the “lactobacillogenic” effect in the cecum and that these were released from the HV β-glucan by hydrolysis catalyzed by extracellular β-glucanases secreted by other cecal residents (
40). We do not know whether any proportion of the HV β-glucan was digested in proximal regions of the gut, but evidence of an effect on the cecal microbiota suggests that this did not occur to any extent. Strains of
L. ruminis were also tested for the ability to utilize oligosaccharides in β-glucan hydrolysates and were found to ferment the DP3 and DP4 fractions. Only two
Lactobacillus species can presently be considered autochthonous to the digestive tract of humans, namely,
L. salivarius and
L. ruminis (reviewed in reference
7). The oral cavity, however, appears to be the likely habitat of
L. salivarius, whereas
L. ruminis seems to be a true resident of the colons of a proportion of healthy humans (
7,
31,
36). The utilization by
L. ruminis of oligosaccharides present in β-glucan hydrolysates as carbon and energy sources is of significance in the development of prebiotics for human consumption because these lactobacilli normally comprise approximately 0.1% of the fecal microbiota, a much greater concentration of bacteria than can be achieved by the administration of probiotic strains (
36). Future work to determine the impact of defined products containing purified oligosaccharides of DP3/DP4 derived from barley β-glucans on
L. ruminis populations in the human colon would clearly be worth pursuing.
The results of our study clearly demonstrate that HV β-glucan can produce a prebiotic effect in the ceca of rats, at least under the specific dietary conditions that were used. While extrapolation of our observations to humans is not yet appropriate, experimental animal studies provide an informative screening method by which products for potential use in human nutrition or medicine can be tested. Lactobacilli and other lactic acid bacteria have recently generated considerable interest as probiotic agents in the prophylaxis or treatment of chronic pouchitis and ulcerative colitis (
5,
17,
18). Thus, food-derived products that stimulate autochthonous
Lactobacillus populations in human colons are of major biotechnological and medical interest.